SU655310A3 - Способ получени производного имидазола - Google Patents

Способ получени производного имидазола

Info

Publication number
SU655310A3
SU655310A3 SU762386215A SU2386215A SU655310A3 SU 655310 A3 SU655310 A3 SU 655310A3 SU 762386215 A SU762386215 A SU 762386215A SU 2386215 A SU2386215 A SU 2386215A SU 655310 A3 SU655310 A3 SU 655310A3
Authority
SU
USSR - Soviet Union
Prior art keywords
imidazole derivatives
methyl
obtaining
imidazole
solution
Prior art date
Application number
SU762386215A
Other languages
English (en)
Russian (ru)
Inventor
Раймонд Вайт Джордж
Original Assignee
Смит Клайн Энд Френч Лабораториз, Лимитед (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смит Клайн Энд Френч Лабораториз, Лимитед (Фирма) filed Critical Смит Клайн Энд Френч Лабораториз, Лимитед (Фирма)
Application granted granted Critical
Publication of SU655310A3 publication Critical patent/SU655310A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SU762386215A 1975-07-31 1976-07-30 Способ получени производного имидазола SU655310A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31968/75A GB1565647A (en) 1975-07-31 1975-07-31 Pharmacologically active compounds 4-substituted-imidazole-5-methanols

Publications (1)

Publication Number Publication Date
SU655310A3 true SU655310A3 (ru) 1979-03-30

Family

ID=10331071

Family Applications (1)

Application Number Title Priority Date Filing Date
SU762386215A SU655310A3 (ru) 1975-07-31 1976-07-30 Способ получени производного имидазола

Country Status (28)

Country Link
JP (1) JPS5219663A (xx)
AR (1) AR213100A1 (xx)
AT (1) AT356668B (xx)
AU (1) AU508262B2 (xx)
BE (1) BE843840A (xx)
CA (1) CA1075702A (xx)
CS (1) CS203054B2 (xx)
DD (1) DD125205A5 (xx)
DE (1) DE2634430A1 (xx)
DK (1) DK316376A (xx)
ES (1) ES450309A1 (xx)
FI (1) FI762191A (xx)
FR (1) FR2319341A1 (xx)
GB (1) GB1565647A (xx)
GR (1) GR61114B (xx)
HU (1) HU174068B (xx)
IL (1) IL50006A0 (xx)
LU (1) LU75495A1 (xx)
NL (1) NL7608505A (xx)
NO (1) NO762659L (xx)
OA (1) OA05405A (xx)
PH (1) PH13417A (xx)
PT (1) PT65377B (xx)
RO (1) RO72312B (xx)
SE (1) SE7608478L (xx)
SU (1) SU655310A3 (xx)
ZA (1) ZA763686B (xx)
ZM (1) ZM9676A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
IE47044B1 (en) 1977-04-20 1983-12-14 Ici Ltd Guanidine derivatives
US4112234A (en) 1977-08-22 1978-09-05 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
USRE31588E (en) * 1977-06-03 1984-05-22 Bristol-Myers Company Imidazolylmethylthioethyl alkynyl guanidines
US4233302A (en) 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
EP0008596A1 (fr) * 1978-09-04 1980-03-19 DEVINTER Europe S.A. Société anonyme dite: Procédé de préparation de dérivés du type 4-hydroxyméthyl imidazole à partir d'esters d'acides 4-imidazole carboxyliques correspondants
US4200760A (en) * 1978-09-26 1980-04-29 Bristol-Myers Company Imidazolylalkylthioalkylamino-ethylene derivatives
JPS5914460B2 (ja) * 1978-12-27 1984-04-04 相互薬工株式会社 H↓2受容体「きつ」抗剤シメチジンの製造法
CN103288742A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种高纯度英加韦林原料的制备方法
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA938556A (en) * 1970-06-25 1973-12-18 Smith Kline And French Laboratories Limited Pharmaceutical compositions containing thiourea derivatives

Also Published As

Publication number Publication date
IL50006A0 (en) 1976-09-30
AR213100A1 (es) 1978-12-15
ZA763686B (en) 1977-05-25
NO762659L (xx) 1977-02-01
RO72312B (ro) 1984-03-31
FR2319341A1 (fr) 1977-02-25
GR61114B (en) 1978-09-13
PH13417A (en) 1980-03-30
DE2634430A1 (de) 1977-02-10
AU508262B2 (en) 1980-03-13
DK316376A (da) 1977-02-01
BE843840A (fr) 1977-01-06
JPS5219663A (en) 1977-02-15
DD125205A5 (xx) 1977-04-06
ATA552376A (de) 1979-10-15
AU1644776A (en) 1978-02-02
PT65377A (en) 1976-08-01
CS203054B2 (en) 1981-02-27
ES450309A1 (es) 1977-12-01
FI762191A (xx) 1977-02-01
GB1565647A (en) 1980-04-23
RO72312A (ro) 1984-03-15
HU174068B (hu) 1979-10-28
OA05405A (fr) 1981-02-28
NL7608505A (nl) 1977-02-02
AT356668B (de) 1980-05-12
FR2319341B1 (xx) 1979-01-12
SE7608478L (sv) 1977-02-01
LU75495A1 (xx) 1977-03-03
PT65377B (en) 1978-01-19
ZM9676A1 (en) 1977-07-21
CA1075702A (en) 1980-04-15

Similar Documents

Publication Publication Date Title
JP6843120B2 (ja) (4s)−4−(4−シアノ−2−メトキシフェニル)−5−エトキシ−2,8−ジメチル−1,4−ジヒドロ−1,6−ナフチリジン−3−カルボキサミドの調製方法および電気化学的方法による(4s)−4−(4−シアノ−2−メトキシフェニル)−5−エトキシ−2,8−ジメチル−1,4−ジヒドロ−1,6−ナフチリジン−3−カルボキサミドの回収
SU655310A3 (ru) Способ получени производного имидазола
EP3564239A1 (en) Aryl hydrocarbon receptor modulator
Iwasaki et al. Convenient syntheses of 4, 4-dimethoxy esters and ketones
EP0271552B1 (en) Derivatives of all-trans- and 13-cis retinoic acid and methods for preparing same
EP0072531A1 (de) Neue Cyclophosphamid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
Kress Chemistry of pyrimidine. II. Synthesis of pyrimidine N-oxides and 4-pyrimidinones by reaction of 5-substituted pyrimidines with peracids. Evidence for covalent hydrates as reaction intermediates
SU671727A3 (ru) Способ получени производных 5-нитроимидазола
SU576919A3 (ru) Способ получени производных амида масл ной кислоты
FI63750C (fi) Foerfarande foer framstaellning av 2-oxo-pyrrolidin-n-alkylamider
Guirado et al. Cathodic acylation of 1, 2-acenaphthenedione
Griffey et al. Efficient syntheses of [3-15N] uracil and [3-15N] thymine
Koizumi et al. Reaction mechanism of cathodic crossed coupling of acetone with unsaturated compounds in acidic solution.
GB2035313A (en) Preparation of N-cyano-N'-methyl- N''-(2-mercaptoethyl)-guanidine
KORMAN et al. Rearrangement of 2, 3-Bis (p-aminophenyl)-2, 3-butanediol. Structure of Amphenone B
Laćan et al. Electrochemical Reduction of Intermediates in the Vitamin B6 Production. II. Reduction of 2-Methoxymethyl-3-nitro-4-methyl-5-cyano-6-chloropyridine
Singh et al. Electro-catalyzed cynoarylmethylation of isatin for synthesis of 3-hydroxy-3-cynomethyl oxindole derivatives
DE19744257B4 (de) Beta-Carboline und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen
FI61311B (fi) Nytt foerfarande foer framstaellning av 2-acylamino-bentsylaminer
EP1395595B1 (en) Tetramerous derivative of indole-3-carbinol with anti-carcinogenic activity and method of synthesis of said derivative
NO156942B (no) Analogifremgangsmaate for fremstilling av nye terapeutiske virksomme 1,2-dihydropyrido (3,4-b)-pyraziner.
SU725427A1 (ru) Производные пиримидо (5,4- @ ) изохинолина и способ их получени
SU451242A3 (ru) Способ получени производных бензоциклогептаизохинолина
SU1413103A1 (ru) 5-(N-Карбобензокси)-аминонафталин-1-сульфохлорид в качестве полупродукта в синтезе замещенных 5-аминонафталин-1-сульфамидов,используемых в качестве детектируемых групп ферментных субстратов
EP3143185B1 (de) Verfahren zur elektrochemischen aminierung an bor-dotierten diamantanoden